We used causal forest machine learning to re-analyze data from a randomized study evaluating oseltamivir in hospitalized patients with lower respiratory tract infection. Influenza virus infected patients had 26% lower risk of clinical failure when treated with oseltamivir (95% CI 3.2% - 48.0%), suggesting it may be a useful intervention.